Cargando…
Circ_0092367 Inhibits EMT and Gemcitabine Resistance in Pancreatic Cancer via Regulating the miR-1206/ESRP1 Axis
Gemcitabine is the first-line treatment for patients with pancreatic cancer (PC), yet most patients develop resistance to gemcitabine. Recent studies showed that circular RNAs (circRNAs) have important regulatory roles in PC progression and chemoresistance. In this study, the ability of circRNA circ...
Autores principales: | Yu, Shuo, Wang, Min, Zhang, Hang, Guo, Xingjun, Qin, Renyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622583/ https://www.ncbi.nlm.nih.gov/pubmed/34828307 http://dx.doi.org/10.3390/genes12111701 |
Ejemplares similares
-
miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EMT axis
por: Yang, Rui-Meng, et al.
Publicado: (2017) -
Circ_0043256 upregulates KLF2 expression by absorbing miR‐1206 to suppress the tumorigenesis of lung cancer
por: Zhou, Ying, et al.
Publicado: (2023) -
CircESRP1 enhances metastasis and epithelial–mesenchymal transition in endometrial cancer via the miR-874-3p/CPEB4 axis
por: Shi, Rui, et al.
Publicado: (2022) -
Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT
por: Harvey, Samuel E., et al.
Publicado: (2018) -
Hsa_circ_0007401 regulates gemcitabine resistance of pancreatic cancer through the hsa-miR-6509-3p/fli1 axis
por: Han, Chenchen, et al.
Publicado: (2023)